Laboratory evaluation demonstrates 100% diagnostic accuracy for HbE detection during rapid HbA1c chromatography, suggesting effective prevention of miscalculated glycemic levels.
Background: Hb variants are often incidentally detected during HbA1c testing and can cause interference. We evaluated the ability of the ARKRAY HA-8180V HPLC system operating in fast mode (FM) to identify Hb variants, particularly HbE, in samples submitted for HbA1c testing based on characteristic retention times (RTs). Methods: Chromatograms of samples tested for HbA1c were analyzed; those showing predefined abnormal chromatographic patterns suggestive of Hb variants were further evaluated using capillary electrophoresis (CE) and β- and α-globin gene sequencing. RTs were recorded. Results: ABart'sH samples produced falsely low HbA1c values. Artificially decreased HbA1c was detected in 21/27 (77.8%) HbEE samples. ARKRAY HA-8180V FM analysis yielded reproducible RTs for HbE, achieving 100% sensitivity, specificity, and accuracy in the validation cohort. Conclusions: HbE and thalassemia variants can interfere with HbA1c quantification. ARKRAY HA-8180V FM chromatogram review allows reliable detection of HbE and prevents misinterpretation of HbA1c results.
No takes yet. Share an insight, caveat, or question.
Mayoon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: